Cherrington Julie M 4
4 · Mirati Therapeutics, Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Cherrington Julie M
Director
Transactions
- Sale
Common Stock
2022-01-19$116.07/sh−1,475$171,203→ 2,546 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021.